UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 267

Sortiert nach

Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma

Journal of clinical oncology, 2015-09, Vol.33 (25), p.2803-2811

2015

Link zum Volltext

Verfügbarkeit prüfen

Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction

Journal of clinical oncology, 2011-02, Vol.29 (6), p.610-618

2011

Link zum Volltext

Verfügbarkeit prüfen

In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer

Journal of clinical oncology, 2009-12, Vol.27 (35), p.5944-5951

2009

Link zum Volltext

Verfügbarkeit prüfen

Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2912-2919

2013

Link zum Volltext

Verfügbarkeit prüfen

Statistical Challenges in the Analysis of Health-Related Quality of Life in Cancer Clinical Trials

Journal of clinical oncology, 2016-06, Vol.34 (16), p.1953-1956

2016

Link zum Volltext

Verfügbarkeit prüfen

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

Journal of clinical oncology, 2017-12, Vol.35 (35), p.3898-3905

2017

Link zum Volltext

Verfügbarkeit prüfen

Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

Journal of clinical oncology, 2012-02, Vol.30 (6), p.631-636

2012

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3353-3360

2012

Link zum Volltext

Verfügbarkeit prüfen

Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials

Journal of clinical oncology, 2011-08, Vol.29 (23), p.3163-3172

2011

Link zum Volltext

Verfügbarkeit prüfen

Obinutuzumab (GA101) in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Results From the Phase II GAUGUIN Study

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2920-2926

2013

Link zum Volltext

Verfügbarkeit prüfen

Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203

Journal of clinical oncology, 2006-10, Vol.24 (28), p.4620-4625

2006

Link zum Volltext

Verfügbarkeit prüfen

Reply to Z. Gao et al

Journal of clinical oncology, 2024-03, Vol.42 (9), p.1088-1089

2024

Link zum Volltext

Verfügbarkeit prüfen

Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102

Journal of clinical oncology, 2007-04, Vol.25 (10), p.1160-1168

2007

Link zum Volltext

Verfügbarkeit prüfen

Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial

Journal of clinical oncology, 2006-11, Vol.24 (31), p.4976-4982

2006

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia

Journal of clinical oncology, 2017-01, Vol.35 (3), p.298-305

2017

Link zum Volltext

Verfügbarkeit prüfen

International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy

Journal of clinical oncology, 2024-01, Vol.42 (1), p.70-80

2024

Link zum Volltext

Verfügbarkeit prüfen

Survival End Point Reporting in Randomized Cancer Clinical Trials: A Review of Major Journals

Journal of clinical oncology, 2008-08, Vol.26 (22), p.3721-3726

2008

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

Journal of clinical oncology, 2008-10, Vol.26 (30), p.4906-4911

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma

Journal of clinical oncology, 2008-11, Vol.26 (32), p.5156-5164

2008

Link zum Volltext

Verfügbarkeit prüfen

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

Journal of clinical oncology, 2021-06, Vol.39 (18), p.JCO2003175-1970

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase II randomized, open-labelled, multicenter study of safety and efficacy of combination brigatinib and carboplatin-pemetrexed therapy or brigatinib monotherapy as first-line treatment in patients with advanced ALK-positive non–small cell lung cancer (IFCT-2101 MASTERPROTOCOL ALK)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS9144-TPS9144

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 267

Suche als RSS-Feed

Aktive Filter

PublikationsformTexte

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(267)
Mit Volltextzugriff
(267)

Publikationsform

Artikel
(267)

Sprache

Erscheinungsjahr

n.n

Thema

Oncology
(71)
Humans
(64)
Life Sciences & Biomedicine
(63)
Science & Technology
(63)
Female
(50)
Male
(46)
Middle Aged
(45)
Adult
(39)
Aged
(39)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Tumors
(33)
Treatment Outcome
(27)
Disease-Free Survival
(25)
Life Sciences
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(22)
Cancer Research
(21)
Aged, 80 And Over
(15)
Kaplan-Meier Estimate
(15)
Hematologic And Hematopoietic Diseases
(14)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission

Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma

Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction

In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer

Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease

Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study

Statistical Challenges in the Analysis of Health-Related Quality of Life in Cancer Clinical Trials

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study

Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial

Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials

Obinutuzumab (GA101) in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Results From the Phase II GAUGUIN Study

Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study

Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203

Reply to Z. Gao et al

Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102

Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia

International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy

Survival End Point Reporting in Randomized Cancer Clinical Trials: A Review of Major Journals

Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

A phase II randomized, open-labelled, multicenter study of safety and efficacy of combination brigatinib and carboplatin-pemetrexed therapy or brigatinib monotherapy as first-line treatment in patients with advanced ALK-positive non–small cell lung cancer (IFCT-2101 MASTERPROTOCOL ALK)

Aktive Filter

Suchergebnisse filtern